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Myocardial InfarctionAbstract Background: Blood glucose is known to be elevated in patients presenting with acute
coronary syndromes. However a gap in knowledge exists regarding effective management strategies
once admitted to acute care units. It is also unknown what factors (if any) predict elevated glucose
values during initial presentation. Objectives: Objectives of the study were to characterize blood glu-
cose control in patients admitted to the cardiac care unit (CCU) in Qatar and to determine predic-
tive factors associated with high glucose levels (>10 mmol/l) on admission to the CCU. Setting: All
data for this study were obtained from the CCU at Heart Hospital in Doha, Qatar. Method: A
retrospective chart review was completed for patients admitted to the CCU in Qatar from
October 1st, 2012 to March 31st, 2013, of which 283 were included. Baseline characteristics (age,
gender, nationality, medical history, smoking status, type of acute coronary syndrome), capillary
and lab blood glucose measurements, and use of insulin were extracted. Time spent in glucose
ranges of <4, 4 to <8, 8 to <10, and >10 mmol/1 was calculated manually. Univariate and
multivariate logistic regression were performed to assess factors associated with high glucose on
admission. The primary analysis was completed with capillary data and a sensitivity analysis was
completed using laboratory data.Main outcome measure: Blood glucose values measured on admis-
sion and throughout length of stay in the CCU. Results: Capillary blood glucose data showed
majority of time was spent in the range of >10 mmol/l (41.95%), followed by 4–8 mmol/l
(35.44%), then 8–10 mmol/l (21.45%), and finally <4 mmol/l (1.16%). As a sensitivity analysis,
laboratory data showed very similar findings. Diabetes, hypertension, and non-smoker status
36 K.J. Wilby et al.predicted glucose values >10 mmol/l on admission (p< 0.05) in a univariate analysis but only dia-
betes remained significant in a multivariate model (OR 23.3; 95% CI, 11.5–47.3). Conclusion:
Diabetes predicts high glucose values on hospital admission for patients with ACS and patients
are not being adequately controlled throughout CCU stay.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Diabetes and cardiovascular disease are highly prevalent in
Western societies and are rapidly becoming major health con-
cerns within other global regions (Wild et al., 2004). Both are
associated with high rates of morbidity and place significant
cost and resource burdens on healthcare systems (Zhang
et al., 2010). In addition to the burden on society, these dis-
eases greatly affect patients and their caregivers. Patients com-
monly develop symptoms and/or complications that negatively
influence their quality of life, while increasing potential for
physician visits and hospitalizations (Sudore et al., 2012;
Ciechanowski et al., 2003; Nishi et al., 2014).
The relationship between Acute Coronary Syndromes
(ACS) and diabetes is poorly understood, however both those
with and without diabetes commonly present to the hospital
with elevated glucose levels upon admission for an ACS event
(Kosiborod, 2009). The mechanism for serum glucose eleva-
tion in non-those without diabetes is unclear but may be a
marker of undiagnosed diabetes or impaired glucose tolerance
(Norhammar et al., 2002). The effect is concerning, as hyper-
glycemia is associated with a higher risk of mortality and com-
plications in patients experiencing ACS (Donahoe et al., 2007;
Deedwania et al., 2008). This is true for glucose levels on
admission, as well as glucose levels throughout hospitalization
(Kosiborod, 2009). It is speculated that abnormal glucose
metabolism may have a role in left ventricular remodeling
(Hofsten et al., 2009; Nicolau et al., 2007). However, this
remains yet to be confirmed.
A key area of interest is determination of the most effective
management strategy for ACS patients presenting with hyper-
glycemia on admission to the critical care unit. There is evidence
that glucose normalization upon admission to a hospital setting
can reduce mortality risk, without any major increases in
adverse effects (Kosiborod, 2009). Moreover, greater reduction
of glucose over 24 h in those without diabetes has predicted
lower mortality (Goyal et al., 2009). However, large studies in
critical care settings have demonstrated increased morbidity
and mortality in patients who received intensive glycemic con-
trol, likely due to hypoglycemia (Finfer et al., 2009). As such,
current clinical practice guidelines recommend maintaining
blood glucose in the range of 7–11 mmol/l for patients present-
ing with ACS (Canadian Diabetes Association Practice
Guidelines Expert Committee, 2013).
In recent years, the Middle East has observed a sharp
increase in the prevalence of both diabetes and cardiovascular
diseases (Habibzadeh, 2012). The State of Qatar is a member
state of the Gulf Cooperation Council (GCC) and is currently
undergoing healthcare reform, with comprehensive strategies
being implemented to develop a modernized world-class
healthcare system (Supreme Council of Health, 2012).
However, this system is challenged by very high rates of bothdiabetes and cardiovascular disease within local populations
(Supreme Council of Health, 2012; Bener et al., 2009;
Almahmeed et al., 2012). There is currently a gap in knowledge
regarding the presentation and management of ACS patients
in Qatar, and whether or not practice trends mirror that of
other international centers. Specifically, it is unknown how
glucose is managed upon presentation in patients with ACS
and what (if any) predictive factors are associated with high
glucose levels on admission.
The primary objective of this study was to characterize
capillary blood glucose control in ACS patients admitted to
the cardiac care unit (CCU) in Qatar. A secondary objective
was to determine predictive factors associated with high glu-
cose levels (>10 mmol/l) on admission to the CCU.
Approval was received from the Institutional Review Boards
at both Hamad Medical Corporation and Qatar University.
2. Methods
2.1. Design and patients
This study was a retrospective chart review of all patients
admitted with a diagnosis of ACS to the CCU at Heart
Hospital in Qatar, from October 1, 2012 to March 31, 2013.
Inclusion criteria were patients admitted to the CCU at the
Heart Hospital with a diagnosis of ST segment elevated
myocardial infarction (STEMI), non-STEMI, or unstable ang-
ina that had at least one documented blood glucose measure-
ment during CCU stay. Patients who were not admitted for
ACS or who did not have a plasma glucose level taken at
any time during admission to the CCU were excluded from
the study.
2.2. Outcomes
The primary endpoint was characterization of blood glucose
control in patients admitted to the CCU through determina-
tion of the time spent in blood glucose ranges of <4, 4 to
<8, 8 to <10, and >10 mmol/l measured through capillary
mechanisms. These ranges were chosen based on institution
levels of hypoglycemia (<4) and hyperglycemia (>10). The
threshold for initiation of sliding scale insulin at the center
studied is 10 mmol/l and therefore correlates to institutional
definitions of control. The secondary endpoint was the
determination of factors associated with initial glucose levels
>10 mmol/l on admission to the CCU.
2.3. Data collection
A standardized data extraction tool was developed for collect-
ing patient data. Patients were identified using hospital records
Table 1 Baseline characteristics of included patients
(n= 283).
Characteristic N (%)
Age (years)
<40 34 (12.0)
40–50 91 (32.2)
50–60 103 (36.4)
60–70 43 (15.2)
>70 12 (4.2)
Gender
Male 270 (95.4)
Female 13 (4.6)
Weight (kg) [mean, SD] 75.2 (15.3)
Nationality
South Asia 189 (66.8)
Gulf Cooperation Council (GCC) 41 (14.5)
North Africa 22 (7.8)
Middle East (aside from GCC) 18 (6.4)
East Asia 9 (3.2)
Other 4 (1.4)
Co-morbidities
Diabetes 125 (44.2)
Coronary Artery Disease 161 (56.9)
Hypertension 132 (46.6)
Dyslipidemia 54 (19.1)
Current smoker 163 (57.6)
Infarct type
STEMI 225 (79.5)
NSTEMI 35 (12.4)
Unstable angina 27 (9.5)
0% 1.16%
35.44%
21.45%
41.95%
< 2.2 2.2 - 4 4.0 - 8.0 8.0 - 10.0 > 10
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Blood glucose control for patients with acute coronary syndromes 37for all admissions to the CCU during the time period of inter-
est. Data were collected from the patient’s healthcare record in
paper form. Blood glucose values measured by capillary and
laboratory methods were documented. Capillary glucose data
were obtained from a blood glucose monitoring form standard
for all patients. Blood glucose data measured by the laboratory
were obtained from printed copies in the patient’s file. The
baseline characteristics of age, gender, weight, nationality,
co-morbidities (diabetes, hypertension, coronary artery dis-
ease), smoking status, and infarct type were documented.
Based on nationalities found, categories were determined as
South Asian (India, Sri Lanka, Bangladesh, Pakistan, and
Nepal), East Asian (Philippines, Indonesia), North Africa
(Egypt, Sudan, Ethiopia, Eritrea), Middle Eastern (Palestine,
Syria, Jordan, Yemen, Iran), GCC (Qatar, Saudi Arabia,
Kuwait, UAE, Bahrain, Oman), and Western (USA, UK,
South Africa, Sweden).
2.4. Statistical analysis
Time spent in each pre-established glucose range was calcu-
lated manually. From the patient’s first capillary measurement,
it was assumed that the patient remained in the specified range
until the next glucose measurement was given. For example, if
a patient’s glucose measured 12 mmol/l at time 0 but measured
8 mmol/l at time 4 h, it was determined that the patient spent
4 h within the range of >10 mmol/l. A sensitivity analysis
employing the same methodology but using solely laboratory
values was also completed.
Results pertaining to the time spent in each glucose range
were reported using descriptive statistics. Univariate logistic
regression was used to assess the association between baseline
characteristics and glucose levels >10 mmol/l on admission.
Baseline characteristics assessed were gender, age, weight,
nationality, presence of diabetes, presence of coronary artery
disease, presence of hypertension, presence of dyslipidemia,
active smoking status, and type of infarction. A subgroup
analysis was completed to assess the same variables in known
diabetes patients. Multivariate logistic regression was used to
analyze any factor deemed significant from univariate results.
Results were shown as odds ratios (OR) with 95% confidence
intervals (CIs), and a p-value of <0.05 was considered sta-
tistically significant. All inferential analyses were completed
using Statistical Package for Social Sciences (SPSS) version 21.Figure 1 Time spent in glucose ranges based on capillary data.3. Results
A total of 377 patients were identified for review for which 283
met pre-established inclusion criteria. Patients were excluded
for not having a diagnosis of ACS or did not have a blood glu-
cose level reported. Baseline characteristics are presented in
Table 1. Notably, the majority of patients were of South
Asian nationality (66.80%) with an average age of 51.4 years.
Almost half (44.2%) had a documented diagnosis of diabetes.
The primary endpoint for capillary data showed that the
majority time was spent in the blood glucose range of
>10 mmol/l (41.95% of time), followed by 4.0–8.0 mmol/l
(35.44%), then 8.0–10.0 (21.45%), and finally 2.2–4.0
(1.16%). No patient spent any time below the blood glucose
value of 2.2 mmol/l, as captured by data extraction (Fig. 1).
When the 4.0–8.0 mmol/l and 8.0–10.0 mmol/l categories werecombined, the time spent surpassed that of the >10 mmol/l
range with a value of 56.89%. The sensitivity analysis showed
very similar results with the most time spent in the range of
>10 mmol/l (46.39%), then 4.0–8.0 mmol/l (36.28%), then
8.0–10.0 mmol/l (16.20%), and finally 2.2–4.0 mmol/l
(1.13%). No time was documented in the range below
2.2 mmol/l.
Univariate analysis found that the presence of diabetes (OR
26.3 95% CI [13.4–51.6]) and the presence of hypertension
(OR 2.884 95% CI [1.762–4.721]) to be significantly associated
with initial glucose values >10 mmol/l. Active smokers were
less likely to have high values, as compared to non-smokers
38 K.J. Wilby et al.(OR 0.577 95% CI [0.356–0.933]). However, only the presence
of diabetes remained significant when these factors were com-
bined in a multivariate regression model (OR 23.3 95% CI
[11.5–47.3], r2 = 0.53). For diabetes patients alone, no factor
was significantly associated with initial glucose values
>10 mmol/l.
4. Discussion
This study characterized blood glucose control for patients
with ACS in the CCU in the Heart Hospital in Qatar, and it
assessed predictive factors of patients presenting with high glu-
cose values. Findings showed that patients spent a large pro-
portion of time (42%) within the glucose range above
10 mmol/l. Additionally, it was found that the diagnosis of dia-
betes was the only significant predictive factor for patients pre-
senting with initial glucose levels above 10 mmol/l, when
corrected for hypertension and smoking status. Interestingly,
the majority of patients admitted to the CCU with ACS were
of South Asian nationality and almost half were diabetes
patients.
The findings concerning the primary outcome demonstrate
a large proportion of time spent in a glucose range above
10 mmol/l. According to the pre-defined blood glucose ranges,
patients spent the most time in this range. However, when the
two ranges representing normal non-fasting glycemic values
were combined (4–8 mmol/l and 8–10 mmol/l), more patients
spent time within these ranges as compared to >10 mmol/l
(56.89% vs. 41.95%, respectively). Even with 41.95% who
had values >10 mmol/l, these findings show that a large pro-
portion of patients are not achieving glycemic targets, accord-
ing to institutional policies and international guidelines
(Canadian Diabetes Association Clinical Practice Guidelines
Expert Committee, 2013). The reasons for this finding are
not known, however fear of hypoglycemia by healthcare pro-
fessionals, ineffective insulin sliding scale regimens, and con-
text-specific patient values and preferences may all be
contributors. Observations from practice suggest that the fear
of hypoglycemia and patient aversion to insulin may be pri-
mary factors, which are causing clinical staff (including physi-
cians, nurses, and pharmacists) to not proactively advocate for
optimal use of sliding scale insulin, when necessary. These
considerations match previously speculated ones generated
from studies that found similar results in other settings
(Kosiborod, 2009).
The high blood glucose values (>10 mmol/l) on admission
were also of concern, especially for diabetes patients. While no
cause and effect relationship can be determined, it is possible
that physiological mechanisms during ACS result in elevated
glucose levels (Opie, 2008). However, an alternative explana-
tion may be that diabetes patients in Qatar are not being ade-
quately controlled as outpatients, leading to higher glucose
levels during times of acute stress. Diabetes has been a target
disease for prevention and treatment in Qatar (Supreme
Council of Health, 2012) yet it is unknown if efforts are result-
ing in better treatment control. The results of this study war-
rant further investigation to determine the degree of diabetes
control in Qatar.
As described above, available evidence for therapeutic deci-
sion-making in this area is scarce and mostly consists of obser-
vational studies. This study adds to the literature regardingglucose control in ACS patients by bringing a diverse perspec-
tive from a rapidly developing healthcare system. There are
very few studies published from critical care settings in the
Middle East, which is unfortunate because the ethnic diversity
of local populations (including large amounts of expatriates)
can serve as a form of generalizability to many international
settings. Our findings show that patients in Qatar are not
achieving target glucose values during ACS care and call for
other centers to perform similar analyses for characterization
of international care. The results also confirm that diabetes
is associated with high glucose levels in ACS (especially within
an ethnically diverse population) and provide justification for
further evaluation of inpatient and outpatient diabetes care.
This study has limitations that should be addressed. First,
the retrospective observational design limits the ability to
determine cause and effect for associations found. Therefore,
it is mostly hypothesis generating for further studies within
the GCC context and elsewhere. Secondly, due to limitations
of data available (i.e. charting practices and hospital record
coding), clinical outcomes were unable to be obtained.
Therefore, no associations could be made regarding effects
of hyperglycemia on mortality or other morbidities. Finally
the method of calculating the time spent in each glucose range
is prone to error based on the assumption that patients
remained within a category until the subsequent measurement,
however the sensitivity analysis yielded similar findings.
Blood glucose control in patients with ACS is an emerging
area of interest and optimal blood glucose targets during hos-
pital admission for these patients remain yet to be defined.
This study assessed hospital practices in the only coronary care
unit in Qatar and found that most patients are achieving glu-
cose values >10 mmol/l during CCU stay. It can be concluded
from this study that diabetes predicts high blood glucose val-
ues on admission for patients with ACS and that insulin pro-
tocols are not being well adhered to. As such, prospective
international trials are needed to determine the effect of blood
glucose control on patient outcomes and to optimize blood
glucose targets. Outpatient diabetes care should also be exam-
ined to ensure inadequate long-term control is not putting
patients at risk for ACS within this setting.Acknowledgments
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